{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "SEELOS THERAPEUT. DL-,001", "longName": "Seelos Therapeutics, Inc.", "messageBoardId": "finmb_402470124", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -6.058792, "regularMarketPrice": 0.783, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1198825200000, "priceHint": 4, "epsTrailingTwelveMonths": -0.66, "epsForward": -0.45, "epsCurrentYear": -0.54, "priceEpsCurrentYear": -1.4499999, "sharesOutstanding": 121811000, "bookValue": -0.099, "fiftyDayAverage": 0.655424, "fiftyDayAverageChange": 0.127576, "fiftyDayAverageChangePercent": 0.19464651, "twoHundredDayAverage": 0.8393365, "twoHundredDayAverageChange": -0.056336522, "twoHundredDayAverageChangePercent": -0.067120306, "marketCap": 96466384, "forwardPE": -1.74, "priceToBook": -7.909091, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.050500035, "regularMarketTime": 1683871215, "regularMarketDayHigh": 0.783, "regularMarketDayRange": "0.783 - 0.783", "regularMarketDayLow": 0.783, "regularMarketVolume": 3380, "regularMarketPreviousClose": 0.8335, "bid": 0.794, "ask": 0.822, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.783, "averageDailyVolume3Month": 54, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.28599998, "fiftyTwoWeekLowChangePercent": 0.5754527, "fiftyTwoWeekRange": "0.497 - 1.3906", "fiftyTwoWeekHighChange": -0.6076, "fiftyTwoWeekHighChangePercent": -0.4369337, "fiftyTwoWeekLow": 0.497, "fiftyTwoWeekHigh": 1.3906, "earningsTimestamp": 1680692340, "earningsTimestampStart": 1680692340, "earningsTimestampEnd": 1680692340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "NXEN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "300 Park Avenue", "address2": "2nd Floor", "city": "New York", "state": "NY", "zip": "10022", "country": "United States", "phone": "646 293 2100", "website": "https://seelostherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Raj  Mehra J.D., Ph.D.", "age": 62, "title": "Founder, Chairman, CEO & Pres", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 854732, "fmt": "854.73k", "longFmt": "854,732"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael J. Golembiewski", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 454827, "fmt": "454.83k", "longFmt": "454,827"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kimberly  Farrand", "title": "Sr. Director of Clinical Devel. & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anthony  Marciano", "title": "Chief Communications Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Gopal  Krishna Ph.D.", "title": "Head of Manufacturing & Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Tim  Whitaker M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen  Fusaro", "title": "Sr. VP & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}